Published in Small on February 05, 2010
Cancer theranostics: the rise of targeted magnetic nanoparticles. Trends Biotechnol (2011) 1.60
Influence of synthetic superparamagnetic iron oxide on dendritic cells. Int J Nanomedicine (2011) 0.94
In vivo migration of dendritic cells labeled with synthetic superparamagnetic iron oxide. Int J Nanomedicine (2011) 0.88
Exploiting the tumor microenvironment for theranostic imaging. NMR Biomed (2011) 0.85
Effect of magnetic nanoparticles on apoptosis and cell cycle induced by wogonin in Raji cells. Int J Nanomedicine (2012) 0.85
Tungsten oxide nanorods: an efficient nanoplatform for tumor CT imaging and photothermal therapy. Sci Rep (2014) 0.83
Theranostic Magnetic Nanostructures (MNS) for Cancer. Cancer Treat Res (2015) 0.81
Induced clustered nanoconfinement of superparamagnetic iron oxide in biodegradable nanoparticles enhances transverse relaxivity for targeted theranostics. Magn Reson Med (2013) 0.81
Biocompatible nanocomposite for PET/MRI hybrid imaging. Int J Nanomedicine (2012) 0.81
Multifunctional Nanocarpets for Cancer Theranostics: Remotely Controlled Graphene Nanoheaters for Thermo-Chemosensitisation and Magnetic Resonance Imaging. Sci Rep (2016) 0.80
Biodegradable double nanocapsule as a novel multifunctional carrier for drug delivery and cell imaging. Int J Nanomedicine (2015) 0.78
In vivo anticancer evaluation of the hyperthermic efficacy of anti-human epidermal growth factor receptor-targeted PEG-based nanocarrier containing magnetic nanoparticles. Int J Nanomedicine (2014) 0.78
Folate/NIR 797-conjugated albumin magnetic nanospheres: synthesis, characterisation, and in vitro and in vivo targeting evaluation. PLoS One (2014) 0.77
Bovine serum albumin nanoparticles with fluorogenic near-IR-emitting squaraine dyes. ACS Appl Mater Interfaces (2013) 0.75
The orphan receptor GPR17 identified as a new dual uracil nucleotides/cysteinyl-leukotrienes receptor. EMBO J (2006) 2.17
Treatment with statins after induction of focal ischemia in rats reduces the extent of brain damage. Arterioscler Thromb Vasc Biol (2003) 2.08
The recently identified P2Y-like receptor GPR17 is a sensor of brain damage and a new target for brain repair. PLoS One (2008) 1.44
CX3CL1 is neuroprotective in permanent focal cerebral ischemia in rodents. J Neurosci (2011) 1.29
Inhibition of class I histone deacetylases unveils a mitochondrial signature and enhances oxidative metabolism in skeletal muscle and adipose tissue. Diabetes (2012) 1.22
Stimulation of AT2 receptor exerts beneficial effects in stroke-prone rats: focus on renal damage. J Hypertens (2009) 1.18
New insights into brain damage in stroke-prone rats: a nuclear magnetic imaging study. Stroke (2002) 1.18
The interleukin-8 (IL-8/CXCL8) receptor inhibitor reparixin improves neurological deficits and reduces long-term inflammation in permanent and transient cerebral ischemia in rats. Mol Med (2007) 1.11
Thin deposits and patterning of room-temperature-switchable one-dimensional spin-crossover compounds. Langmuir (2011) 1.09
Water-dispersible sugar-coated iron oxide nanoparticles. An evaluation of their relaxometric and magnetic hyperthermia properties. J Am Chem Soc (2011) 1.09
Size-dependent toxicity and cell interaction mechanisms of gold nanoparticles on mouse fibroblasts. Toxicol Lett (2012) 1.08
Catalytic enantioselective Friedel-Crafts alkylation of indoles with nitroalkenes by using a simple thiourea organocatalyst. Angew Chem Int Ed Engl (2005) 1.08
Design of water-based ferrofluids as contrast agents for magnetic resonance imaging. J Colloid Interface Sci (2011) 1.06
One-pot synthesis and characterization of size-controlled bimagnetic FePt-iron oxide heterodimer nanocrystals. J Am Chem Soc (2008) 1.05
Predictive toxicology of cobalt nanoparticles and ions: comparative in vitro study of different cellular models using methods of knowledge discovery from data. Toxicol Sci (2011) 1.04
Statins: multiple mechanisms of action in the ischemic brain. Neuroscientist (2007) 1.03
Directed palladation: fine tuning permits the catalytic 2-alkenylation of indoles. Chem Commun (Camb) (2005) 1.03
Targeting mannose-binding lectin confers long-lasting protection with a surprisingly wide therapeutic window in cerebral ischemia. Circulation (2012) 1.03
Analysis of pathological events at the onset of brain damage in stroke-prone rats: a proteomics and magnetic resonance imaging approach. J Neurosci Res (2004) 1.03
Problems and challenges in the development and validation of human cell-based assays to determine nanoparticle-induced immunomodulatory effects. Part Fibre Toxicol (2011) 1.02
Gold nanoparticles induce cytotoxicity in the alveolar type-II cell lines A549 and NCIH441. Part Fibre Toxicol (2009) 1.01
Treatment with LXR agonists after focal cerebral ischemia prevents brain damage. FEBS Lett (2008) 1.01
Proepileptic influence of a focal vascular lesion affecting entorhinal cortex-CA3 connections after status epilepticus. J Neuropathol Exp Neurol (2008) 0.98
Rosuvastatin treatment prevents progressive kidney inflammation and fibrosis in stroke-prone rats. Am J Pathol (2007) 0.97
Pentoxifylline prevents spontaneous brain ischemia in stroke-prone rats. J Pharmacol Exp Ther (2004) 0.96
Mutant PrP suppresses glutamatergic neurotransmission in cerebellar granule neurons by impairing membrane delivery of VGCC α(2)δ-1 Subunit. Neuron (2012) 0.96
Phase-transfer-catalyzed asymmetric aza-Henry reaction using N-carbamoyl imines generated in situ from alpha-amido sulfones. Angew Chem Int Ed Engl (2005) 0.95
The suitability of different cellular in vitro immunotoxicity and genotoxicity methods for the analysis of nanoparticle-induced events. Nanotoxicology (2010) 0.95
Synthesis and coating of cobalt ferrite nanoparticles: a first step toward the obtainment of new magnetic nanocarriers. Langmuir (2007) 0.94
Hypoxia/reoxygenation cardiac injury and regeneration in zebrafish adult heart. PLoS One (2013) 0.94
Molecular mechanisms involved in the asymmetric interaction between cannabinoid and opioid systems. Psychopharmacology (Berl) (2005) 0.93
Robust ligand shells for biological applications of gold nanoparticles. Langmuir (2008) 0.92
Rosuvastatin, but not simvastatin, provides end-organ protection in stroke-prone rats by antiinflammatory effects. Arterioscler Thromb Vasc Biol (2005) 0.92
Metabolism: a bottleneck in in vitro toxicological test development. The report and recommendations of ECVAM workshop 54. Altern Lab Anim (2006) 0.91
Peroxisome proliferator-activated receptor {alpha} agonism prevents renal damage and the oxidative stress and inflammatory processes affecting the brains of stroke-prone rats. J Pharmacol Exp Ther (2010) 0.91
Cellular distribution and degradation of cobalt ferrite nanoparticles in Balb/3T3 mouse fibroblasts. Toxicol Lett (2011) 0.91
Anti-inflammatory effects of AT1 receptor blockade provide end-organ protection in stroke-prone rats independently from blood pressure fall. J Pharmacol Exp Ther (2004) 0.91
Predictive toxicology of cobalt ferrite nanoparticles: comparative in-vitro study of different cellular models using methods of knowledge discovery from data. Part Fibre Toxicol (2013) 0.91
The role of HMG-CoA reductase inhibition in endothelial dysfunction and inflammation. Vasc Health Risk Manag (2007) 0.91
Activation of NF-kB and ERK1/2 after permanent focal ischemia is abolished by simvastatin treatment. Neurobiol Dis (2006) 0.90
Paclitaxel enhances therapeutic efficacy of the F8-IL2 immunocytokine to EDA-fibronectin-positive metastatic human melanoma xenografts. Cancer Res (2012) 0.90
Decreased contralateral putamen [I]FP-CIT SPECT uptake in hyperglycemic hemichorea-hemiballismus. Eur Neurol (2011) 0.89
Comparative study of ZnO and TiO₂ nanoparticles: physicochemical characterisation and toxicological effects on human colon carcinoma cells. Nanotoxicology (2012) 0.89
Genotoxicity and morphological transformation induced by cobalt nanoparticles and cobalt chloride: an in vitro study in Balb/3T3 mouse fibroblasts. Mutagenesis (2009) 0.89
Micro- and nanopatterning by lithographically controlled wetting. Nat Protoc (2012) 0.89
Targeted delivery of silver nanoparticles and alisertib: in vitro and in vivo synergistic effect against glioblastoma. Nanomedicine (Lond) (2014) 0.89
Differential modulation of uncoupling protein 2 in kidneys of stroke-prone spontaneously hypertensive rats under high-salt/low-potassium diet. Hypertension (2013) 0.88
Magnetic resonance imaging of human endothelial progenitors reveals opposite effects on vascular and muscle regeneration into ischaemic tissues. Cardiovasc Res (2009) 0.88
Ambipolar multi-stripe organic field-effect transistors. Adv Mater (2011) 0.87
Amorphous silica nanoparticles do not induce cytotoxicity, cell transformation or genotoxicity in Balb/3T3 mouse fibroblasts. Mutat Res (2011) 0.87
Anti-inflammatory properties of drugs acting on the renin-angiotensin system. Drugs Today (Barc) (2005) 0.87
Organocatalytic trifluoromethylation of imines using phase-transfer catalysis with phenoxides. A general platform for catalytic additions of organosilanes to imines. Chem Commun (Camb) (2011) 0.87
Direct observation of single-molecule magnets organized on gold surfaces. Angew Chem Int Ed Engl (2003) 0.87
A molecular thermometer for nanoparticles for optical hyperthermia. Nano Lett (2013) 0.86
Terutroban, a thromboxane/prostaglandin endoperoxide receptor antagonist, increases survival in stroke-prone rats by preventing systemic inflammation and endothelial dysfunction: comparison with aspirin and rosuvastatin. J Pharmacol Exp Ther (2010) 0.86
Protein corona affects the relaxivity and MRI contrast efficiency of magnetic nanoparticles. Nanoscale (2013) 0.86
In vivo imaging of glia activation using 1H-magnetic resonance spectroscopy to detect putative biomarkers of tissue epileptogenicity. Epilepsia (2012) 0.86
Longitudinal tracking of human fetal cells labeled with super paramagnetic iron oxide nanoparticles in the brain of mice with motor neuron disease. PLoS One (2012) 0.85
Energy-barrier enhancement by ligand substitution in tetrairon(III) single-molecule magnets. Angew Chem Int Ed Engl (2004) 0.85
Human skin penetration of cobalt nanoparticles through intact and damaged skin. Toxicol In Vitro (2012) 0.85
Phase transfer catalyzed enantioselective Strecker reactions of alpha-amido sulfones with cyanohydrins. J Org Chem (2006) 0.85
Mechanisms of toxicity induced by SiO2 nanoparticles of in vitro human alveolar barrier: effects on cytokine production, oxidative stress induction, surfactant proteins A mRNA expression and nanoparticles uptake. Nanotoxicology (2012) 0.85
Direct access to enantiomerically enriched alpha-amino phosphonic acid derivatives by organocatalytic asymmetric hydrophosphonylation of imines. J Org Chem (2006) 0.84
Superparamagnetic colloidal nanocrystal clusters coated with polyethylene glycol fumarate: a possible novel theranostic agent. Nanoscale (2010) 0.83
Protective effects of Brassica oleracea sprouts extract toward renal damage in high-salt-fed SHRSP: role of AMPK/PPARα/UCP2 axis. J Hypertens (2015) 0.83